Viridian Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 02/17/2026 | 14.38 M | $447.64 M | 17.43% | 17.59% |
| BLACKROCK, INC. | 02/12/2026 | 6.43 M | $200.16 M | 18.48% | 7.86% |
| VANGUARD GROUP INC | 01/29/2026 | 5.61 M | $174.65 M | 29.55% | 6.86% |
| BELLEVUE GROUP AG | 02/17/2026 | 4.36 M | $135.64 M | 100.00% | 5.33% |
| FAIRMOUNT FUNDS MANAGEMENT LLC | 02/17/2026 | 3.91 M | $121.82 M | 13.14% | 4.79% |
| VR ADVISER, LLC | 02/17/2026 | 3.88 M | $120.83 M | 0.00% | 4.75% |
| STATE STREET CORP | 02/13/2026 | 3.47 M | $107.88 M | 35.72% | 4.24% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/17/2026 | 3.44 M | $107.04 M | 42.24% | 4.21% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 3.04 M | $94.69 M | 108.06% | 3.72% |
| DEEP TRACK CAPITAL, LP | 02/13/2026 | 2.52 M | $78.57 M | -53.07% | 3.09% |
| NOVO HOLDINGS A/S | 02/17/2026 | 2.38 M | $74.07 M | 0.00% | 2.91% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 1.99 M | $62.01 M | 12.80% | 2.44% |
| BAKER BROS. ADVISORS LP | 02/17/2026 | 1.97 M | $61.36 M | 13.03% | 2.41% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.97 M | $61.35 M | 75.62% | 2.41% |
| TANG CAPITAL MANAGEMENT LLC | 02/17/2026 | 1.79 M | $55.79 M | -36.94% | 2.19% |
| EVERSEPT PARTNERS, LP | 02/17/2026 | 1.78 M | $55.46 M | -7.38% | 2.18% |
| FISHER ASSET MANAGEMENT, LLC | 02/09/2026 | 1.78 M | $55.40 M | 48.21% | 2.18% |
| MORGAN STANLEY | 02/13/2026 | 1.74 M | $54.09 M | 805.60% | 2.13% |
| AVORO CAPITAL ADVISORS LLC | 03/16/2026 | 1.50 M | $46.68 M | 100.00% | 1.83% |
| LOOMIS SAYLES & CO L P | 02/12/2026 | 1.48 M | $46.09 M | -4.46% | 1.81% |
| KYNAM CAPITAL MANAGEMENT, LP | 02/17/2026 | 1.47 M | $45.76 M | -66.79% | 1.80% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/17/2026 | 1.44 M | $44.91 M | -44.70% | 1.76% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 1.41 M | $44.01 M | -23.95% | 1.73% |
| MARSHALL WACE, LLP | 02/13/2026 | 1.38 M | $42.81 M | 58.28% | 1.68% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 1.26 M | $39.34 M | 65.33% | 1.55% |
| JENNISON ASSOCIATES LLC | 01/30/2026 | 1.15 M | $35.91 M | 100.00% | 1.41% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.12 M | $34.73 M | 36.84% | 1.36% |
| JPMORGAN CHASE & CO | 02/11/2026 | 1.01 M | $31.44 M | 226.80% | 1.24% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.00 M | $31.14 M | 100.00% | 1.22% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 990.12 K | $30.81 M | 302.88% | 1.21% |
| VIVO CAPITAL, LLC | 02/13/2026 | 982.58 K | $30.58 M | 0.00% | 1.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 922.77 K | $28.72 M | -12.07% | 1.13% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 884.53 K | $27.53 M | 3.86% | 1.08% |
| 02/17/2026 | 858.63 K | $26.72 M | 100.00% | 1.05% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 790.02 K | $24.59 M | -35.25% | 0.97% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 788.08 K | $24.52 M | -31.74% | 0.96% |
| CANDRIAM S.C.A. | 04/30/2026 | 785.10 K | $24.43 M | -8.73% | 0.96% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 748.96 K | $23.31 M | 25.80% | 0.92% |
| NUVEEN, LLC | 02/12/2026 | 742.34 K | $23.10 M | 358.61% | 0.91% |
| 5AM VENTURE MANAGEMENT, LLC | 02/17/2026 | 736.60 K | $22.92 M | 0.00% | 0.90% |
| FIRST TURN MANAGEMENT, LLC | 02/13/2026 | 690.53 K | $21.49 M | 100.00% | 0.84% |
| CITADEL ADVISORS LLC | 02/17/2026 | 679.69 K | $21.15 M | 778.46% | 0.83% |
| NORTHERN TRUST CORP | 02/17/2026 | 668.42 K | $20.80 M | 7.66% | 0.82% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 555.59 K | $17.29 M | -13.02% | 0.68% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 517.40 K | $16.10 M | 113.53% | 0.63% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 503.87 K | $15.68 M | 148.43% | 0.62% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 479.76 K | $14.93 M | -48.82% | 0.59% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 460.13 K | $14.32 M | 237.63% | 0.56% |
| ROSALIND ADVISORS, INC. | 02/12/2026 | 450.00 K | $14.00 M | -25.00% | 0.55% |
| ALGERT GLOBAL LLC | 02/17/2026 | 425.04 K | $13.23 M | 100.00% | 0.52% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Viridian Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 271 institutional investors and hedge funds held shares of Viridian Therapeutics Inc. The most heavily invested institutionals were:
Fisher Asset Management, LLC: 1.77 M
Candriam S.C.A.: 711,739
Nuveen, LLC: 604,914
Pictet Asset Management Holding SA: 314,031
UBS Group AG: 307,134
Bank of New York Mellon Corp: 216,525
131.84% of Viridian Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 115.57 M shares in the last 24 months. This purchase volume represents approximately $3.43 B in transactions.